Venous thromboembolic events in isolated severe traumatic brain injury

Objective: The purpose of this study was to investigate the effect of prophylactic anticoagulation on the incidence of venous thromboembolic events (VTE) in patients suffering from isolated severe traumatic brain injury (TBI). Materials and Methods: Retrospective matched case-control study in adult...

Full description

Bibliographic Details
Main Authors: Shahin Mohseni, Peep Talving, Lydia Lam, Linda S Chan, Crystal Ives, Demetrios Demetriades
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Journal of Emergencies, Trauma and Shock
Subjects:
Online Access:http://www.onlinejets.org/article.asp?issn=0974-2700;year=2012;volume=5;issue=1;spage=11;epage=15;aulast=Mohseni
_version_ 1828761296542105600
author Shahin Mohseni
Peep Talving
Lydia Lam
Linda S Chan
Crystal Ives
Demetrios Demetriades
author_facet Shahin Mohseni
Peep Talving
Lydia Lam
Linda S Chan
Crystal Ives
Demetrios Demetriades
author_sort Shahin Mohseni
collection DOAJ
description Objective: The purpose of this study was to investigate the effect of prophylactic anticoagulation on the incidence of venous thromboembolic events (VTE) in patients suffering from isolated severe traumatic brain injury (TBI). Materials and Methods: Retrospective matched case-control study in adult patients sustaining isolated severe TBI (head AIS ≥3, with extracranial AIS ≤2) receiving VTE prophylaxis while in the surgical intensive care unit from 1/2007 through 12/2009. Patients subjected to VTE prophylaxis were matched 1:1 by age, gender, glasgow coma scale (GCS) score at admission, presence of hypotension on admission, injury severity score, and head abbreviated injury scale (AIS) score, with patients who did not receive chemical VTE prophylaxis. The primary outcome measure was VTE. Secondary outcomes were SICU and hospital length of stay (HLOS), adverse effects of anticoagulation, and mortality. Results: After propensity matching, 37 matched pairs were analysed. Cases and controls had similar demographics, injury characteristics, rate of craniotomies/craniectomies, SICU LOS, and HLOS. The median time of commencement of VTE prophylaxis was 10 days. The incidence of VTE was increased 3.5-fold in the controls compared to the cases (95% CI 1.0-12.1, P=0.002). The mortality was higher in patients who did not receive anticoagulation (19% vs. 5%, P=0.001). No adverse outcomes were detected in the anticoagulated patients. Conclusion: Prophylactic anticoagulation decreases the overall risk for clinically significant VTE in patients with severe isolated TBI. Prospective validation of the timing and safety of chemical VTE prophylaxis in these instances is warranted.
first_indexed 2024-12-11T01:26:58Z
format Article
id doaj.art-8dbee4dc5e6341eb9c684ec31bdcd57b
institution Directory Open Access Journal
issn 0974-2700
language English
last_indexed 2024-12-11T01:26:58Z
publishDate 2012-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Emergencies, Trauma and Shock
spelling doaj.art-8dbee4dc5e6341eb9c684ec31bdcd57b2022-12-22T01:25:29ZengWolters Kluwer Medknow PublicationsJournal of Emergencies, Trauma and Shock0974-27002012-01-0151111510.4103/0974-2700.93102Venous thromboembolic events in isolated severe traumatic brain injuryShahin MohseniPeep TalvingLydia LamLinda S ChanCrystal IvesDemetrios DemetriadesObjective: The purpose of this study was to investigate the effect of prophylactic anticoagulation on the incidence of venous thromboembolic events (VTE) in patients suffering from isolated severe traumatic brain injury (TBI). Materials and Methods: Retrospective matched case-control study in adult patients sustaining isolated severe TBI (head AIS ≥3, with extracranial AIS ≤2) receiving VTE prophylaxis while in the surgical intensive care unit from 1/2007 through 12/2009. Patients subjected to VTE prophylaxis were matched 1:1 by age, gender, glasgow coma scale (GCS) score at admission, presence of hypotension on admission, injury severity score, and head abbreviated injury scale (AIS) score, with patients who did not receive chemical VTE prophylaxis. The primary outcome measure was VTE. Secondary outcomes were SICU and hospital length of stay (HLOS), adverse effects of anticoagulation, and mortality. Results: After propensity matching, 37 matched pairs were analysed. Cases and controls had similar demographics, injury characteristics, rate of craniotomies/craniectomies, SICU LOS, and HLOS. The median time of commencement of VTE prophylaxis was 10 days. The incidence of VTE was increased 3.5-fold in the controls compared to the cases (95% CI 1.0-12.1, P=0.002). The mortality was higher in patients who did not receive anticoagulation (19% vs. 5%, P=0.001). No adverse outcomes were detected in the anticoagulated patients. Conclusion: Prophylactic anticoagulation decreases the overall risk for clinically significant VTE in patients with severe isolated TBI. Prospective validation of the timing and safety of chemical VTE prophylaxis in these instances is warranted.http://www.onlinejets.org/article.asp?issn=0974-2700;year=2012;volume=5;issue=1;spage=11;epage=15;aulast=MohseniAnticoagulationisolated severe head injurymortalitytraumatic brain injuryvenous thromboembolic event
spellingShingle Shahin Mohseni
Peep Talving
Lydia Lam
Linda S Chan
Crystal Ives
Demetrios Demetriades
Venous thromboembolic events in isolated severe traumatic brain injury
Journal of Emergencies, Trauma and Shock
Anticoagulation
isolated severe head injury
mortality
traumatic brain injury
venous thromboembolic event
title Venous thromboembolic events in isolated severe traumatic brain injury
title_full Venous thromboembolic events in isolated severe traumatic brain injury
title_fullStr Venous thromboembolic events in isolated severe traumatic brain injury
title_full_unstemmed Venous thromboembolic events in isolated severe traumatic brain injury
title_short Venous thromboembolic events in isolated severe traumatic brain injury
title_sort venous thromboembolic events in isolated severe traumatic brain injury
topic Anticoagulation
isolated severe head injury
mortality
traumatic brain injury
venous thromboembolic event
url http://www.onlinejets.org/article.asp?issn=0974-2700;year=2012;volume=5;issue=1;spage=11;epage=15;aulast=Mohseni
work_keys_str_mv AT shahinmohseni venousthromboemboliceventsinisolatedseveretraumaticbraininjury
AT peeptalving venousthromboemboliceventsinisolatedseveretraumaticbraininjury
AT lydialam venousthromboemboliceventsinisolatedseveretraumaticbraininjury
AT lindaschan venousthromboemboliceventsinisolatedseveretraumaticbraininjury
AT crystalives venousthromboemboliceventsinisolatedseveretraumaticbraininjury
AT demetriosdemetriades venousthromboemboliceventsinisolatedseveretraumaticbraininjury